The metabolism of oestradiol and 17a-ethinyloestradiol to their 2-hydroxy derivatives is an important determinant in their biological effects. In this work, we have investigated which rat or human cytochrome P-450 isoenzymes are involved in catalysing these reactions. Oestradiol 2-hydroxylation was catalysed by a wide variety of rat cytochrome P-450s from gene families P4501A, P45011B, P45011C and P450IIIA. Interestingly, 17a-ethinyloestradiol, which only differs structurally from oestradiol at a position distant from the site of oxidation, was metabolized predominantly by members of the P45011C gene subfamily. In order to establish which enzymes are responsible for the oxidation of these substrates in man, antibodies to rat liver cytochrome P-450 isoenzymes were used to inhibit these reactions in a panel of human liver microsomal fractions. Also, possible correlations between the proteins recognized by the antibodies and the 2-hydroxylation rate were determined. These experiments provide evidence that 2-hydroxylation of 17ac-ethinyloestradiol in man is catalysed by cytochromes from the P45011C, P45011E and P450111A gene families. In contrast, the major proteins involved in oestradiol metabolism are from the P4501A gene family, although members of the P45011C and P45011E gene families may also play a role. These data demonstrate that the differences in the capacity of rat P-450s to metabolize these substrates are also present in the comparable enzymes involved in man, and that a variety of factors will determine the rate of disposition of these compounds in man.
INTRODUCTION
The predominant route of oxidative metabolism of the endogenous steroid hormone oestradiol and of the oral contraceptive steroid 17a-ethinyloestradiol in both rat and man is cytochrome P-450-dependent 2-hydroxylation to form the catechol oestrogens 2-hydroxyoestradiol and 2-hydroxyethinyloestradiol [1] [2] [3] [4] [5] . Since the compounds differ from each other only in the presence of the 17a substitutent, the question arises whether the same enzyme(s) metabolize both the endogenous and the synthetic oestrogens. Early publications on experiments in the rat referred to the catechol metabolites of both compounds being formed by the cytochrome P-450-dependent oestrogen hydroxylase [4] [5] [6] [7] . Dannan et al. [8] , however, were able to demonstrate in studies utilizing ten purified rat liver P-450s that three forms, which they designated P-450UT-A P-450BNF-B and P-450ISF-G' exhibited the highest 2-hydroxylase activities. In a separate study Ryan et al. [9] examined the catalytic activity of three purified rat P-450s and showed that P-450h (P-450UT-A) had the highest activity. In the rat, therefore, there is some direct evidence for the involvement of different isoenzymes in oestradiol 2-hydroxylation. In man, Guengerich et al. [10] described the immunoinhibition of oestradiol 2-hydroxylase by an antibody to P-450NF (P450111A1) in human liver microsomes. Similarly Guengerich [11] has also recently described the inhibition of 17a-ethinyloestradiol 2-hydroxylation by this antibody, although purified P-450NF had only relatively low catalytic 17a-ethinyloestradiol 2-hydroxylase activity. While these data are consistent with P-450NF being a major enzyme involved in both oestradiol and 17a-ethinyloestradiol 2-hydroxylation, the potential involvement of other enzymes has not been explored thoroughly.
The aim of the present study was (1) to determine the activity of different P-450 forms purified from rats in the 2-hydroxylation of oestradiol and 17a-ethinyloestradiol and (2) to evaluate whether similar enzymes catalyse these metabolic reactions in man.
MATERIALS AND METHODS Chemicals
Ethinyloestradiol, oestradiol, mestranol, ascorbic acid, DLdilauryl phosphatidylcholine and NADPH were purchased from the Sigma Chemical Company Ltd., Poole, Dorset, U.K. The radiolabelled steroids [6,7-3H] oestradiol and 17a- [6,7-3H] ethinyloestradiol were purchased from New England Nuclear, Stevenage, Herts., U.K. All other reagents were purchased from BDH Chemical Company Ltd., Poole, Dorset, U.K., and were of analytical grade.
Purified rat hepatic cytochromes P450 and anti-(cytochrome P450) antibodies Rat hepatic cytochromes P-450, rabbit anti-(rat cytochrome P-450) antibodies and purified cytochrome P-450 reductase were isolated as previously described [12] [13] [14] . The antibodies to rat P450IIE1 and human P45011D were generously supplied by Dr Oestrogen 2-hydroxylase activity of purified rat cytochromes P450 Purified rat hepatic cytochrome P-450s were reconstituted and activity was determined. Incubations contained cytochrome P-450 (2 nmol), DL-dilauryl phosphatidylcholine (1 mg) and cytochrome P-450 reductase (10000 units). Components were mixed in approx. 50#1d of 10 mM-phosphate buffer (pH 7.4) and incubated for 5 min at 37 'C. Oestrogen 2-hydroxylase activity was determined by incubating reconstituted cytochromes P-450 with either oestradiol or ethinyloestradiol (25 /sM; 1 uCi) and ascorbic acid (1 mM)/NADPH (0.6 mM) in 25 ml Erlenmeyer flasks. The total incubation volume was 3 ml in Tris/HCl buffer (20 mM; pH 7.4). The reaction, for 30 min at 37 'C, was initiated after a 2 min preincubation period by the addition of NADPH and terminated by extraction with diethyl ether (1 x 5 ml) following the addition of mestranol as internal standard (4,ug 16 human livers by differential ultracentrifugation as described previously [5] . Microsomal protein was determined by the method of Lowry et al. [17] and cytochrome P-450 by the method of Omura & Sato [18] .
Oestrogen 2-hydroxylase activity was determined in incubations (45 min at 37°C) containing microsomal protein (0.5 mg), oestradiol or 17a-ethinyloestradiol (25 mM), ascorbic acid (1 mM) and NADPH (0.6 mM) in a total incubation volume of 3 ml. In immunoinhibition studies (six livers), microsomal protein (0.5 mg) was preincubated for 20 min either with specific antibody or with preimmune serum (2.5 mg of IgG). Enzyme activity was then determined as above and metabolites quantified by h.p.l.c.
Western blot analysis
Human liver microsomes (7.5 ug) were run on SDS/PAGE (9 %) and then transferred to nitrocellulose [19] in 20 mM-sodium phosphate containing 20 % methanol at 250 mA for 16 h. Filters were washed in 50 mM-Tris (pH 7.9) containing 250 mM-NaCl and 0.05 % Tween 20 (TBST; 2 x 10 min) then blocked with lowfat dried milk powder (3 %, w/v, in TBST). Polyclonal antibodies raised against purified rat P-450 isoenzymes UTI isoenzymes UTI (P450IIAI), PBla (P450IIC6), PB3a (P450IIB1), PB2c (P450111A), MCla (P450IA2) and P452 (P450IVA) were used at a dilution of 1:500. Antibodies to rat P450IIE1 and human P4501ID were used in a similar way. Bound antibody was visualized using horseradish-peroxidase-linked donkey anti-(rabbit IgG) (1: 1000; 1 h) and autoradiography, followed by '25I-Protein A labelling (5 ,Ci in TBST; 1 h). This procedure considerably increased the sensitivity of the assay and also allowed visualization using the peroxidase substrate 4-chloro-1-naphthol if required. Relative cytochrome P-450 content was determined from the autoradiographs using a Joyce-Loebel scanning densitometer. Linearity was assessed from serial dilutions of the microsomal samples. Each gel also contained different amounts of the antigen being quantified. This enabled standard curves to be generated.
RESULTS
Ethinyloestradiol 2-hydroxylase activities of purified rat hepatic cytochrome P-450s are shown in Table 1 . Interestingly, enzymes within the P45011C gene sub-family, i.e. PBla, PBlb and PB2a, had by far the highest activity, the activity of PBla being almost 10-fold greater than that of P-450s from other gene families. PBlb had approximately half of the activity of PBla (the structural differences between PBla and PBlb are not clearly defined at this time; however, they both have identical N-terminal sequences to P450IIC6 [13] ). The other member of this family with ethinyloestradiol 2-hydroxylase activity was the male-predominant form (P45011C12; Levin form h). Intriguingly, the protein with highest activity towards 17a-ethinyloestradiol (PBla) had no activity towards oestradiol (Fig. 1) ; PBlb did however exhibit some activity. Almost all the other proteins tested from gene families P450IA (Fig. 2) , P450IIB, P450IlC and P450IIIA had activity towards oestradiol. Indeed, for many of these proteins, the activities measured were similar. One point of interest was the large difference in activity of P4501IB2 (PB3b) and P450IIB1 (PB3a), as these proteins share 97% sequence identity at the amino acid level.
The above data indicate that many rat cytochrome P-450 forms can catalyse the 2-hydroxylation of oestradiol, but the Table 1 . Activity of purified rat hepatic cytochromes P-450 Enzyme activities were determined as described in the Materials and methods section. Values given are the average of 2 determinations. Gene nomenclature is according to Nebert et al. [16] 17a-Ethinyl- oxidation of 17a-ethinyloestradiol is more restricted to members of the P450IlC gene family. In order to establish the relative roles of different P-450s in the metabolism of these compounds in human liver, a series of P-450 antibodies was used as inhibitors of oestradiol and 17a-ethinyloestradiol metabolism in human liver microsomal fractions. In addition, Western blot analysis using these antibodies was carried out to determine the relative concentrations of P-450 forms in a further ten samples and to establish whether the levels of specific isoenzymes correlated with the rate of oestradiol or ethinyloestradiol metabolism. In a panel of 16 human livers, the 2-hydroxylation of oestradiol was up to 3-fold higher than that of 17a-ethinyloestradiol ( Table 2 ). The metabolism of oestradiol was also subject to larger individual variation (approx. 7-fold) relative to that of ethinyloestradiol (3-fold) . Interestingly, the rates of metabolism of the two substrates correlated with each other and with the total cytochrome P-450 content (Fig. 3) . Comparison of the relative cytochrome P-450 isoenzyme content determined by Western blot analysis showed significant correlations between oestradiol metabolism and the expression of P450IA and P45011E proteins. Oestradiol metabolism also correlated with proteins in the P45011C gene family (bands 2 and 3) ( Table 3 , Fig. 4 ). The metabolism of 17a-ethinyloestradiol, however, was most highly correlated with the levels of P45011C (band 2) and P450IIIA proteins. A correlation with P45011E protein (band 2) was also observed; however, this may be fortuitous because of one sample with high activity (Fig. 5) . Proteins of the P45011A or P450IlD and the P4501VA gene families did not appear to play a significant role in the metabolism of either substrate, as the level of expression of the proteins detected by Western blot analysis did not correlate with 2-hydroxylase activity.
In agreement with the findings with the purified rat liver proteins and the correlations described above, the antibody to P450IIC6 (PBla) was an effective inhibitor of human liver 17a-ethinyloestradiol 2-hydroxylase activity. The rate of metabolism was reduced to 65, 45, 39, 38, 1.1 and 49 % of control activities (Table 4) . With oestradiol as substrate, however, this antibody (Table 5 ). This is in agreement with the significant correlation between metabolism and the level of P4501A protein. However, this antibody had essentially no effect on 17ac-ethinyloestradiol 2-hydroxylase activity, which is consistent with the lack of activity of the purified rat proteins of this gene family towards this substrate. The antibody to P450IA2 (MCla) also partially inhibited oestradiol metabolism. The antibodies to P450IIB1 and P450IIIA were not effective inhibitors of either oestradiol or 17a-ethinyloestradiol metabolism. In the latter case, however, this may be because the antibody is a poor inhibitor of P450IIA-mediated 
DISCUSSION
In view of the structural similarity between oestradiol and 17cc-ethinyloestradiol, there is a surprising difference in the ability of cytochrome P-450 isoenzymes to metabolize these substrates in the 2-position. 17a-Ethinyloestradiol was metabolized at a much higher rate by proteins from the P45011C gene subfamily than by the other P-450s tested. In contrast, a variety of rat liver P-450s from different gene families had the capacity to metabolize oestradiol. The possibility that the P450IIC subfamily may be involved in ethinyloestradiol metabolism in man was confirmed by the findings that the proteins recognized by the antibody to P450IIC6 in human liver correlated with the level of ethinyloestradiol metabolism, and that the antibody was an effective inhibitor of metabolism of this substrate in the samples tested. In most of the microsomal samples inhibition was only partial, which indicates that other enzymes are also involved. This is in agreement with the findings of Guengerich [11] , and our own findings were that proteins from the P450IIIA gene family also appear to be involved. The relative contribution of P450IIIA and P45011C proteins still remains to be clearly established, as unfortunately the antibody to P450IIIA used was not inhibitory. Several enzymes in human liver therefore appear to have the capacity to metabolize 17a-ethinyloestradiol.
The known effects of phenobarbitone on ethinyloestradiol metabolism [20] could be explained by the induction of the members of the P450IlC and P450IIIA families, as these proteins are induced by this compound in the rat. Also, the involvement of P450IIB cannot be precluded. Although some of the enzymes involved in ethinyloestradiol 2-hydroxylation also appear to have the capacity to metabolize oestradiol, e.g. members of the Vol. 267 P450IIC and P450IIE sub-families, there were clear differences in the relative roles of the different P-450s in the disposition of the endogenous oestrogen. For example, the antibody to P450IIC6 was a much poorer inhibitor of oestradiol than of ethinyloestradiol. Also, on the basis of antibody inhibition and the correlation between protein expression, proteins of the P4501A family appear to play an important role in oestradiol metabolism but not in ethinyloestradiol disposition. It is not clear which of the two known members of this gene family are involved, as both of the antibodies to P4501A1 and P450IA2 recognized the same protein in human liver. These data are consistent with the important finding that oestradiol metabolism is increased in cigarette smokers [21] . Pelkonen et al. [22] have demonstrated that cigarette smoking induces a form of P-450 in human liver that contains an epitope recognized by an anti-MC antibodv. It has also been well established in a number of other studies that the rate of theophylline elimination is higher in cigarette smokers than in non-smokers [23] , studies in vitro with human microsomes providing evidence of the involvement of two P-450 isoenzymes [24] . Campbell et al. [25] have implicated a polycyclic aromatic hydrocarbon-inducible P-450 in the metabolism of theophylline. Thus evidence is accumulating that smoking induces enzymes in the P450IA gene family which are at least partially responsible for the metabolism of 7-ethoxyresorufin, theophylline and oestradiol. Smoking does not affect the disposition of 17a-ethinyloestradiol [26, 27] .
Although the relative contributions of specific P-450s to the metabolism of oestradiol and 17a-ethinyloestradiol in human liver appear to be different, it is clear that several P-450 forms will metabolize these compounds. This will account for the general correlation with total P-450 levels and therefore also for the correlation between 2-hydroxylation of oestradiol and 17a-ethinyloestradiol.
The specificity of P-450 isoenzymes in oestradiol and ethinyloestradiol 2-hydroxylation is intriguing. This is particularly the case for the proteins PB3a (P450IIB1) and PB3b (P4501IB2). These proteins are approximately 97% identical at both the protein and DNA levels [28] , and have been shown previously to possess differential catalytic activity towards a number of other mono-oxygenase substrates. However, PB3a is invariably more active [14, [29] [30] . For example, Ryan et al. [31] reported that PB3b catalysed the metabolism of benzphetamine, testosterone at the 16a-position, hexobarbital, 7-ethoxycoumarin and benzo[a]pyrene at rates which were 15-25 % of those catalysed by PB3a. We have made similar observations for the metabolism of resorufin analogues [14] . However, in agreement with the present study, Ryan et al. [32] also found that PB3b has a much higher oestradiol 2-hydroxylase activity than PB3a.
The marked difference in selectivity of the purified cytochromes in oestradiol and 17a-ethinyloestradiol 2-hydroxylation must be attributable to the D-ring 17a-ethinyl substituent. Clearly, therefore, the steroid D-ring must play a role in substrate recognition, at least for some purified cytochromes. This has been shown to be the case for other steroid mono-oxygenase substrates which differ structurally only in the D-ring. For example, PB2a catalyses the 2-hydroxylation of progesterone (17a-acetyl substituent), three times as rapidly as that of testosterone (17/?-hydroxyl substituent [33] ). It is apparent, therefore, that structural modification of the D-ring can affect metabolism on the A-ring which is physically remote from the structural change. It should also be considered that 17a-ethinyloestradiol has been shown to be a suicide substrate for cytochrome P-450 in both rat [34] and human [11] liver. For example, Guengerich [11] demonstrated a 25-30 % loss of spectrally determined P-450 in human liver microsomes in 60 min using a substrate concentration of 100,M. It is possible, therefore, that some inactivation of individual isoenzymes could take place during the 30 min of incubation in the present work. Further studies are needed on this particular point.
